These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36247137)

  • 1. Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib.
    Yasuda H; Tomizawa Y; Harada S; Sasaki M; Komatsu N; Ando J; Hattori N; Ando M
    Heliyon; 2022 Oct; 8(10):e10928. PubMed ID: 36247137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
    Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
    Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
    Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
    Motoyama R; Yamakawa K; Suzuki S; Kusunoki S; Tanaka M
    Rinsho Shinkeigaku; 2011 Oct; 51(10):761-4. PubMed ID: 22019868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
    El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
    Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
    Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
    Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity].
    Nakamura H; Endo M; Sugawara E; Kuwahara M; Kusunoki S; Tanaka F; Takahashi T
    Rinsho Shinkeigaku; 2013; 53(10):799-802. PubMed ID: 24225562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
    Capasso M; Torrieri F; Di Muzio A; De Angelis MV; Lugaresi A; Uncini A
    Clin Neurophysiol; 2002 Mar; 113(3):346-53. PubMed ID: 11897535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
    Tagawa Y; Yuki N; Hirata K
    Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report.
    Kodaira M; Yamamoto K
    Case Rep Neurol; 2013 Jan; 5(1):34-9. PubMed ID: 23525653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody.
    Kawagashira Y; Koike H; Ohyama K; Hashimoto R; Iijima M; Adachi H; Katsuno M; Chapman M; Lunn M; Sobue G
    J Neurol Sci; 2015 Jan; 348(1-2):67-73. PubMed ID: 25467141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-myelin-associated glycoprotein antibody polyneuropathy.
    Briani C; Visentin A; Salvalaggio A; Cacciavillani M; Trentin L
    Eur J Neurol; 2019 Feb; 26(2):371-375. PubMed ID: 30315672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
    Weiss MD; Dalakas MC; Lauter CJ; Willison HJ; Quarles RH
    J Neuroimmunol; 1999 Mar; 95(1-2):174-84. PubMed ID: 10229128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MAG associated cerebellar ataxia and response to rituximab.
    Zis P; Rao DG; Hoggard N; Sarrigiannis PG; Hadjivassiliou M
    J Neurol; 2018 Jan; 265(1):115-118. PubMed ID: 29159464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.
    Dalakas MC
    Ther Adv Neurol Disord; 2018; 11():1756285617746640. PubMed ID: 29403542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
    Galassi G; Tondelli M; Ariatti A; Benuzzi F; Nichelli P; Valzania F
    Int J Neurosci; 2017 May; 127(5):439-447. PubMed ID: 27188752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widening of myelin lamellae in polyneuropathy with immunoglobulin-M monoclonal gammopathy, without activity against myelin-associated glycoprotein, responsive to treatment.
    Vallat JM; Deschamps N; Richard L; Magy L; Devaux J; Mathis S
    Neuromuscul Disord; 2022 Aug; 32(8):678-681. PubMed ID: 35618575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.
    Eurelings M; Moons KG; Notermans NC; Sasker LD; De Jager AE; Wintzen AR; Wokke JH; Van den Berg LH
    Neurology; 2001 Jan; 56(2):228-33. PubMed ID: 11160960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.